Aberrant expression of protein kinases is a hallmark of several cancers, and small mol­ecules targeting specific kinases are in clinical use as cancer therapeutics (Du & Lovly, 2018 ▸; Kannaiyan & Mahadevan, 2018 ▸; Roskoski, 2023 ▸). The gene discussed is WEE1; the disease is cancer.